Eqitx to raise $1.8 million

By Melissa Trudinger
Tuesday, 07 December, 2004

Melbourne-based biotech managed investment group EQiTX (ASX: EQX) will ask shareholders to approve a AUD$1.8 million capital raising to provide working capital for its two projects ZingoTX and VacTX.

The placement, involving the issue of six million new shares at $0.30 plus two million free attaching options with an exercise price of $0.20, is to be underwritten by Cunningham Securities.

Heart valve tissues created from stem cells

The breakthrough should help advance our understanding into how human heart valves develop,...

Breast augmentation procedure uses 3D-printed scaffolds

3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast...

Victoria detects H5N1 avian influenza strain

It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...

Content from other channels on our network

Crushing economics: scaling up canola processing in Australia

The added benefits of bacteria from the cheese-making process

From six weeks to three days: Australian software overhauls US manufacturer's label approvals

Saputo to sell its UK operations to Lactalis

Bulla Dairy Foods appoints Peter Hall as Chief Executive Officer

Muting in practice: when safety becomes a vulnerability

Nozomi Networks and Sophos partner to combine OT and IT security ops

Digital transformation for automotive product manufacturer

Winner of Propel‍-‍AIR robotics and AI sprint announced

Robotic Automation joins Varley Group

Top 3 benefits of aerobic and strength training for chronic disease prevention

32-bed specialist private mental health hospital opens today

$100K fine follows tower crane incident that caused hospital roof collapse

Nexon partners with Dementia Australia to tackle dementia stigma in the workplace

"Migrant worker exploitation" sees NSW aged care provider repay nearly $120K